A case of non-severe COVID-19 complicated by pulmonary embolism.

Respirology Case Reports
Yuto AkiyamaKoichi Fukunaga

Abstract

Novel coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 is rapidly spreading worldwide. A typical clinical manifestation of COVID-19 is pneumonia, which can progress to acute respiratory distress syndrome and respiratory failure. Recent studies have reported that COVID-19 is often accompanied by coagulopathy, and a significant number of patients with severe or critical COVID-19 develop concomitant thrombosis, including pulmonary embolism (PE). However, there are limited reports of the incidence of PE in non-severe COVID-19 patients. Here, we report a case of non-severe COVID-19 complicated by PE, which indicates that the possibility of PE should consistently be considered, even in non-severe cases of COVID-19 without any risk of thrombosis.

References

Feb 29, 2020·The New England Journal of Medicine·Wei-Jie GuanUNKNOWN China Medical Treatment Expert Group for Covid-19
Apr 20, 2020·Journal of Vascular Surgery. Venous and Lymphatic Disorders·Andrea T ObiPeter K Henke
May 1, 2020·Thrombosis Research·Corrado LodigianiUNKNOWN Humanitas COVID-19 Task Force

❮ Previous
Next ❯

Citations

Sep 10, 2020·Revista Do Instituto De Medicina Tropical De São Paulo·Hareton Teixeira VechiManoella do Monte Alves
Jun 14, 2021·Tropical Diseases, Travel Medicine and Vaccines·Sonia Hesam-ShariatiMohammad Bakhtiar Hesam Shariati

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.